Cyclohexyl(1-methyl-1H-pyrazol-3-yl)methanol

Catalog No.: 
ACNRXP965
CAS No.: 
1483270-16-1
Molecular Formula: 
C11H18N2O
Molecular Weight: 
194.28
Cyclohexyl(1-methyl-1H-pyrazol-3-yl)methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$315.00InquiryInquiry
100mg95%$461.00InquiryInquiry
250mg95%$649.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameCyclohexyl(1-methyl-1H-pyrazol-3-yl)methanol
IUPAC Namecyclohexyl(1-methyl-1H-pyrazol-3-yl)methanol
MDL No.MFCD21131713
Molecular FormulaC11H18N2O
Molecular Weight194.28
SMILESOC(C1CCCCC1)C2=NN(C)C=C2
InChI KeyRHTBYFMSDLULMM-UHFFFAOYSA-N
Synonymcyclohexyl(1-methyl-1H-pyrazol-3-yl)methanol;1H-Pyrazole-3-methanol, α-cyclohexyl-1-methyl-
CAS No.1483270-16-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNRXP965 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNXJO630 route compound structure diagram
    ACNXJO63027258-32-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNRXP965 route product structure diagram
    ACNRXP9651483270-16-1
Inquiry

2. ACNRXP965 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNRXP965 route product structure diagram
    ACNRXP9651483270-16-1
Inquiry

3. ACNRXP965 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNRXP965 route product structure diagram
    ACNRXP9651483270-16-1
Inquiry

Comments (0)